A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice

scientific article

A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1172/JCI117923
P932PMC publication ID295845
P698PubMed publication ID7738194

P2093author name stringFerrante A
Mack P
Kumaratilake LM
Prasertsiriroj V
Widmer F
Rathjen DA
P2860cites workInvolvement of reactive oxygen metabolites in the candidacidal activity of human neutrophils stimulated by muramyl dipeptide or tumor necrosis factor.Q54342216
Human neutrophils activated by interferon-gamma and tumour necrosis factor-alpha kill Entamoeba histolytica trophozoites in vitro.Q54346219
Improving on the formulaQ60063860
Augmentation of the human monocyte/macrophage chemiluminescence response during short-term exposure to interferon-gamma and tumour necrosis factor-alphaQ67299759
The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: comparisons with tumor necrosis factor effectsQ67982535
Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulationQ68139886
Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-alpha and -beta: comparison to recombinant interferon-gamma and interleukin-1 alphaQ69806791
Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophilsQ70042400
Stimulation of neutrophils by tumor necrosis factorQ70138077
Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factorQ70322634
Studies on heterologous resistance between Schistosoma mansoni and Fasciola hepatica in inbred ratsQ70329463
Killing of Staphylococcus aureus by tumor necrosis factor-alpha-activated neutrophils. The role of serum opsonins, integrin receptors, respiratory burst, and degranulationQ70504100
Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activityQ72660293
RAPID CHARCOAL ASSAY FOR INTRINSIC FACTOR (IF), GASTRIC JUICE UNSATURATED B12 BINDING CAPACITY, ANTIBODY TO IF, AND SERUM UNSATURATED B12 BINDING CAPACITYQ78361535
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritisQ24564656
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxinQ28306447
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteriaQ29616614
Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical dataQ30906879
Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factorsQ34195478
Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme releaseQ35111591
Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytesQ35582778
Membrane proteins involved in the adherence of Plasmodium falciparum-infected erythrocytes to the endotheliumQ36168059
Human leukocyte acid hydrolases: Characterization of eleven lysosomal enzymes and study of reaction conditions for their automated analysisQ39107231
The common mediator of shock, cachexia, and tumor necrosis.Q39204110
Antiparasitic effects of tumour necrosis factor in vivo and in vitroQ39602770
Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoitesQ40147908
Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparumQ40153660
Antigenic structure of human tumour necrosis factor: Recognition of distinct regions of TNFα by different tumour cell receptorsQ43814208
Separation of mononuclear and polymorphonuclear leucocytes from human blood by the one-step Hypaque-Ficoll method is dependent on blood column heightQ47273348
Molecular Basis of Sequestration in Severe and Uncomplicated Plasmodium falciparum Malaria: Differential Adhesion of Infected Erythrocytes to CD36 and ICAM-lQ47863824
Characterization of permeation pathways in the plasma membrane of human erythrocytes infected with early stages of Plasmodium falciparum: association with parasite developmentQ47902878
Enhanced inhibition of in vitro multiplication of Plasmodium falciparum by stimulated human polymorphonuclear leucocytes.Q47979786
A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.Q53438021
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectPlasmodium falciparumQ311383
Plasmodium chabaudiQ7201860
P304page(s)2315-2323
P577publication date1995-05-01
P1433published inJournal of Clinical InvestigationQ3186904
P1476titleA synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice
P478volume95

Reverse relations

cites work (P2860)
Q33842644A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus
Q33753828A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion
Q37736263FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.
Q35460907In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice
Q33755132Intrapulmonary delivery of tumor necrosis factor agonist peptide augments host defense in murine gram-negative bacterial pneumonia
Q92826319Modelling pathogen load dynamics to elucidate mechanistic determinants of host-Plasmodium falciparum interactions
Q41915336Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels
Q53070035Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation.
Q34002249Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo
Q39826884Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia.

Search more.